SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (9299)6/7/1998 6:27:00 PM
From: Sal Milani  Read Replies (2) | Respond to of 23519
 
VLAD - You're right <Vivus gets $17.00/dose in the US.> I was being much too conservative. The annual report shows $130m in revenues for 8m units or $16/unit. If we use that figure and one unit per week per user, we have
Annual Rev = 10m * (1-.7)*.5*.5*52*16 = $624 million in US.
I'd be happy with half of that !
Sal


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News